AKT1 and glioma: The capacity of sirolimus to inhibit mTOR and induce autophagy was confirmed in U87MG, T98G, and U373 MG glioma cells, where inhibition of the PI3K/AKT/mTOR pathway led to the induction of autophagy without activating apoptosis.